Scientific Name: Cefaclor
Brand Name: Not Available
Company Owner: Eli lilly and co, Ceph international corp, Clonmel healthcare ltd, Hikma pharmaceuticals, Ivax pharmaceuticals inc sub teva pharmaceuticals usa, Marsam pharmaceuticals llc, Ranbaxy pharmaceuticals inc, Teva pharmaceuticals usa inc, Yung shin pharmaceutical industrial co ltd, Acs dobfar info sa, Ranbaxy laboratories ltd, World gen llc
Mechanism Of Action Cefaclor, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that cefaclor interferes with an autolysin inhibitor.
Description of the Drug: Cefaclor is a second generation cephalosporin used to treat a wide variety of infections in the body.
Protein Data Bank: Not Available
Source: DrugBank Online – Retrieved 2023-01-23 from